{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["e86e2c46-950b-485d-b41e-eccb79174d92", "Q3", 28264, "NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)", 134504, "NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)", 2024, "third_quarter", "2024-10-15T10:45:24-04:00", 60000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/e86e2c46-950b-485d-b41e-eccb79174d92/\", \"filing_uuid\": \"e86e2c46-950b-485d-b41e-eccb79174d92\", \"filing_type\": \"Q3\", \"filing_type_display\": \"3rd Quarter - Report\", \"filing_year\": 2024, \"filing_period\": \"third_quarter\", \"filing_period_display\": \"3rd Quarter (July 1 - Sep 30)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/e86e2c46-950b-485d-b41e-eccb79174d92/print/\", \"filing_document_content_type\": \"text/html\", \"income\": null, \"expenses\": \"60000.00\", \"expenses_method\": \"B\", \"expenses_method_display\": \"B\", \"posted_by_name\": \"Beth Anne Cole\", \"dt_posted\": \"2024-10-15T10:45:24-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": \"United States of America\", \"registrant_address_1\": \"1779 Massachusetts Avenue, NW\", \"registrant_address_2\": \"Suite 500\", \"registrant_different_address\": false, \"registrant_city\": \"Washington\", \"registrant_state\": \"DC\", \"registrant_zip\": \"20036\", \"registrant\": {\"id\": 28264, \"url\": \"https://lda.senate.gov/api/v1/registrants/28264/\", \"house_registrant_id\": 30689, \"name\": \"NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)\", \"description\": null, \"address_1\": \"1779 Massachusetts Avenue NW\", \"address_2\": \"Suite 500\", \"address_3\": null, \"address_4\": null, \"city\": \"Washington\", \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"zip\": \"20036\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"CAROLYN SHERIDAN\", \"contact_telephone\": \"+1 202-588-5700\", \"dt_updated\": \"2026-01-29T08:59:11.250000-05:00\"}, \"client\": {\"id\": 134504, \"url\": \"https://lda.senate.gov/api/v1/clients/134504/\", \"client_id\": 12, \"name\": \"NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)\", \"general_description\": null, \"client_government_entity\": false, \"client_self_select\": true, \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": \"DC\", \"ppb_state_display\": \"District of Columbia\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"1996-02-14\"}, \"lobbying_activities\": [{\"general_issue_code\": \"HCR\", \"general_issue_code_display\": \"Health Issues\", \"description\": \"Rare Disease Initiatives. Newborn Screening. Affordable Care Act (ACA) Issues and Enhancements. Step Therapy. Telehealth. Priority Review Voucher Reauthorization. H.R.6892: Medical Nutrition Equity Act of 2023.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 143895, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"MASON\", \"nickname\": null, \"middle_name\": \"OLIVER\", \"last_name\": \"BARRETT\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 141569, \"prefix\": \"ms\", \"prefix_display\": \"MS.\", \"first_name\": \"KARIN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"HOELZER\", \"suffix\": \"phd\", \"suffix_display\": \"PHD\"}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 142139, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"HAYLEY\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"MASON\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 78651, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"HEIDI\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"ROSS\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 146678, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"SUPRAJA\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"SOWMIYANARAYAN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 136, \"name\": \"Centers For Medicare and Medicaid Services (CMS)\"}, {\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"MMM\", \"general_issue_code_display\": \"Medicare/Medicaid\", \"description\": \"Medicare / Medicaid issues impacting patients with rare diseases. Inflation Reduction Act Implementation.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 143895, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"MASON\", \"nickname\": null, \"middle_name\": \"OLIVER\", \"last_name\": \"BARRETT\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 141569, \"prefix\": \"ms\", \"prefix_display\": \"MS.\", \"first_name\": \"KARIN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"HOELZER\", \"suffix\": \"phd\", \"suffix_display\": \"PHD\"}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 142139, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"HAYLEY\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"MASON\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 78651, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"HEIDI\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"ROSS\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 136, \"name\": \"Centers For Medicare and Medicaid Services (CMS)\"}, {\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"PHA\", \"general_issue_code_display\": \"Pharmacy\", \"description\": \"Pharmaceutical issues impacting patients with rare diseases. Orphan Drug Act. H.R.7383/S.1214: RARE Act. Inflation Reduction Act Implementation. PRV Reauthorization. Lab-developed tests.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 143895, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"MASON\", \"nickname\": null, \"middle_name\": \"OLIVER\", \"last_name\": \"BARRETT\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 141569, \"prefix\": \"ms\", \"prefix_display\": \"MS.\", \"first_name\": \"KARIN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"HOELZER\", \"suffix\": \"phd\", \"suffix_display\": \"PHD\"}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 142139, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"HAYLEY\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"MASON\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 78651, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"HEIDI\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"ROSS\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 146678, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"SUPRAJA\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"SOWMIYANARAYAN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 136, \"name\": \"Centers For Medicare and Medicaid Services (CMS)\"}, {\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 34, \"name\": \"Health & Human Services, Dept of (HHS)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"BUD\", \"general_issue_code_display\": \"Budget/Appropriations\", \"description\": \"Appropriations impacting patients with rare diseases. National Institutes of Health (NIH) NCATS Appropriations.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 143895, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"MASON\", \"nickname\": null, \"middle_name\": \"OLIVER\", \"last_name\": \"BARRETT\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 141569, \"prefix\": \"ms\", \"prefix_display\": \"MS.\", \"first_name\": \"KARIN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"HOELZER\", \"suffix\": \"phd\", \"suffix_display\": \"PHD\"}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 139, \"name\": \"Natl Institutes of Health (NIH)\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["e86e2c46-950b-485d-b41e-eccb79174d92"], "units": {}, "query_ms": 49.52727910131216, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}